Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection
- PMID: 17283559
- DOI: 10.2500/ajr.2007.21.2902
Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection
Abstract
Background: Rhinorrhea and nasal congestion are simultaneous symptoms associated with the common cold. This study investigated the efficacy and safety of a combination nasal spray of ipratropium and xylometazoline for simultaneous treatment of these symptoms.
Methods: The trial was a multicenter double-blind, parallel-group, randomized design on patients with common cold symptoms. Patients scored symptoms of runny nose and nasal congestion and recorded adverse events in a diary for up to 7 days. Patients also recorded tissue use. The five test treatments consisted of ipratropium, 0.6 mg/mL, and xylometazoline, 1.0 mg/mL; ipratropium, 0.6 mg/mL, and xylometazoline, 0.5 mg/mL; ipratropium, 0.6 mg/mL; xylometazoline, 1.0 mg/mL; and placebo solution.
Results: Eight hundred sixty-four patients were screened and 786 patients received treatment. One day after treatment there was a clear separation between the scores for the placebo and ipratropium treatment groups for rhinorrhea and between the placebo and xylometazoline treatment groups for congestion. Both ipratropium/xylometazoline 1.0 and ipratropium/xylometazoline 0.5 treatments were superior to xylometazoline with respect to rhinorrhea (p < 0.0001) and superior to ipratropium with respect to nasal congestion scores (p < 0.001). Both the ipratropium combination treatments had significantly lower tissue use than the xylometazoline treatment group (p < 0.0001). Adverse events were distributed equally between the treatments, except mucus tinged with blood, epistaxis, nasal passage irritation, and nasal dryness, which had a higher incidence in the three groups that received medicines containing ipratropium.
Conclusion: The results indicate that a combination medicine of ipratropium and xylometazoline is safe and effective for treatment of rhinorrhea and nasal congestion associated with common cold.
Similar articles
-
OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.Int J Clin Pharmacol Ther. 2009 Dec;47(12):744-51. doi: 10.5414/cpp47744. Int J Clin Pharmacol Ther. 2009. PMID: 19954713
-
Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.Curr Med Res Opin. 2010 Apr;26(4):889-99. doi: 10.1185/03007991003648015. Curr Med Res Opin. 2010. PMID: 20151787 Review.
-
Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial.Am J Rhinol. 1998 Nov-Dec;12(6):441-9. doi: 10.2500/105065898780707919. Am J Rhinol. 1998. PMID: 9883302 Clinical Trial.
-
Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.Ann Intern Med. 1996 Jul 15;125(2):89-97. doi: 10.7326/0003-4819-125-2-199607150-00002. Ann Intern Med. 1996. PMID: 8678385 Clinical Trial.
-
Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold.Expert Opin Pharmacother. 2009 Apr;10(5):889-908. doi: 10.1517/14656560902783051. Expert Opin Pharmacother. 2009. PMID: 19351236 Review.
Cited by
-
Treatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy--A Pro/Con Debate.Lung. 2016 Feb;194(1):15-20. doi: 10.1007/s00408-015-9808-5. Epub 2015 Sep 29. Lung. 2016. PMID: 26420163 Review.
-
Clinical Practice Guidelines for Diagnosis and Management of Cough-Chinese Thoracic Society (CTS) Asthma Consortium.J Thorac Dis. 2018 Nov;10(11):6314-6351. doi: 10.21037/jtd.2018.09.153. J Thorac Dis. 2018. PMID: 30622806 Free PMC article. Review. No abstract available.
-
Factors associated with efficacy of an ibuprofen/pseudoephedrine combination drug in pharmacy customers with common cold symptoms.Int J Clin Pract. 2017 Feb;71(2):e12907. doi: 10.1111/ijcp.12907. Epub 2016 Dec 7. Int J Clin Pract. 2017. PMID: 27925348 Free PMC article.
-
Intranasal ipratropium bromide for the common cold.Cochrane Database Syst Rev. 2013 Jun 19;2013(6):CD008231. doi: 10.1002/14651858.CD008231.pub3. Cochrane Database Syst Rev. 2013. PMID: 23784858 Free PMC article.
-
Anticholinergic drugs in nonallergic rhinitis.World Allergy Organ J. 2009 Aug 15;2(8):162-5. doi: 10.1097/WOX.0b013e3181b35336. World Allergy Organ J. 2009. PMID: 24228813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical